Findings to report for client who is receiving total parenteral nutrition

1. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1 Suppl):1SA–138SA. [PubMed] [Google Scholar]

2. Maroulis J, Kalfarentzos F. Complications of parenteral nutrition at the end of the century. Clin Nutr. 2000;19:295–304. doi: 10.1054/clnu.1999.0089. Available from: http://dx.doi.org/10.1054/clnu.1999.0089. [PubMed] [CrossRef] [Google Scholar]

3. Koretz RL, Lipman TO, Klein S American Gastroenterological Association. AGA technical review on parenteral nutrition. Gastroenterology. 2001;121(4):970–1001. doi: 10.1016/S0016-5085(01)92000-1. Available from: http://dx.doi.org/10.1016/S0016-5085(01)92000-1. [PubMed] [CrossRef] [Google Scholar]

4. Braunschweig CL, Levy P, Sheean PM, Wang X. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr. 2001;74(4):534–542. [PubMed] [Google Scholar]

5. Van den Berghe G. Insulin therapy for the critically ill patient. Clin Cornerstone. 2003;5(2):56–63. doi: 10.1016/S1098-3597(03)90018-4. Available from: http://dx.doi.org/10.1016/S1098-3597(03)90018-4. [PubMed] [CrossRef] [Google Scholar]

6. Marik PE, Pinsky M. Death by parenteral nutrition. Intensive Care Med. 2003;29(6):867–869. doi: 10.1007/s00134-003-1995-5. Available from: http://dx.doi.org/10.1007/s00134-003-1995-5. [PubMed] [CrossRef] [Google Scholar]

7. Anderson AD, Jain PK, MacFie J. Parenteral nutrition in the critically ill. Intensive Care Med. 2003;29(11):2103. doi: 10.1007/s00134-003-1996-4. Available from: http://dx.doi.org/10.1007/s00134-003-1996-4. [PubMed] [CrossRef] [Google Scholar]

8. Fürst P. Comment on "Death by parenteral nutrition" by Marik and Pinsky. Intensive Care Med. 2003;29(11):2102. doi: 10.1007/s00134-003-2023-5. Available from: http://dx.doi.org/10.1007/s00134-003-2023-5. [PubMed] [CrossRef] [Google Scholar]

9. Varga P, Griffiths R, Chiolero R, Nitenberg G, Leverve X, Pertkiewicz M, Roth E, Wernerman J, Pichard C, Preiser JC. Is parenteral nutrition guilty? Intensive Care Med. 2003;29(11):1861–1864. doi: 10.1007/s00134-003-2006-6. Available from: http://dx.doi.org/10.1007/s00134-003-2006-6. [PubMed] [CrossRef] [Google Scholar]

10. Alpers DH. Enteral feeding and gut atrophy. Curr Opin Clin Nutr Metab Care. 2002;5(6):679–683. doi: 10.1097/00075197-200211000-00011. Available from: http://dx.doi.org/10.1097/00075197-200211000-00011. [PubMed] [CrossRef] [Google Scholar]

11. Bistrian BR. Update on total parenteral nutrition. Am J Clin Nutr. 2001;74(2):153–154. [PubMed] [Google Scholar]

12. Jeejeebhoy KN. Total parenteral nutrition: potion or poison? Am J Clin Nutr. 2001;74(2):160–163. [PubMed] [Google Scholar]

13. Richards DM, Deeks JJ, Sheldon TA, Shaffer JL. Home parenteral nutrition: a systematic review. Health Technol Assess. 1997;1(1):i–iii, 1. [PubMed] [Google Scholar]

14. Klein S. A primer of nutritional support for gastroenterologists. Gastroenterology. 2002;122(6):1677–1687. doi: 10.1053/gast.2002.33574. Available from: http://dx.doi.org/10.1053/gast.2002.33574. [PubMed] [CrossRef] [Google Scholar]

15. Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr. 1995;19(6):453–460. doi: 10.1177/0148607195019006453. Available from: http://dx.doi.org/10.1177/0148607195019006453. [PubMed] [CrossRef] [Google Scholar]

16. Guedon C, Schmitz J, Lerebours E, Metayer J, Audran E, Hemet J, Colin R. Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology. 1986;90(2):373–378. [PubMed] [Google Scholar]

17. Pironi L, Paganelli GM, Miglioli M, Biasco G, Santucci R, Ruggeri E, Di Febo G, Barbara L. Morphologic and cytoproliferative patterns of duodenal mucosa in two patients after long-term total parenteral nutrition: changes with oral refeeding and relation to intestinal resection. JPEN J Parenter Enteral Nutr. 1994;18(4):351–354. doi: 10.1177/0148607194018004351. Available from: http://dx.doi.org/10.1177/0148607194018004351. [PubMed] [CrossRef] [Google Scholar]

18. Sedman PC, MacFie J, Palmer MD, Mitchell CJ, Sagar PM. Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br J Surg. 1995;82(12):1663–1667. doi: 10.1002/bjs.1800821226. Available from: http://dx.doi.org/10.1002/bjs.1800821226. [PubMed] [CrossRef] [Google Scholar]

19. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, Soeters PB. Glutamine and the preservation of gut integrity. Lancet. 1993;341(8857):1363–1365. doi: 10.1016/0140-6736(93)90939-E. Available from: http://dx.doi.org/10.1016/0140-6736(93)90939-E. [PubMed] [CrossRef] [Google Scholar]

20. van der Hulst RR, von Meyenfeldt MF, Tiebosch A, Buurman WA, Soeters PB. Glutamine and intestinal immune cells in humans. JPEN J Parenter Enteral Nutr. 1997;21(6):310–315. doi: 10.1177/0148607197021006310. Available from: http://dx.doi.org/10.1177/0148607197021006310. [PubMed] [CrossRef] [Google Scholar]

21. van der Hulst RR, von Meyenfeldt MF, Deutz NE, Stockbrügger RW, Soeters PB. The effect of glutamine administration on intestinal glutamine content. J Surg Res. 1996;61(1):30–34. doi: 10.1006/jsre.1996.0076. Available from: http://dx.doi.org/10.1006/jsre.1996.0076. [PubMed] [CrossRef] [Google Scholar]

22. Ahlman B, Ljungqvist O, Persson B, Bindslev L, Wernerman J. Intestinal amino acid content in critically ill patients. JPEN J Parenter Enteral Nutr. 1995;19(4):272–278. doi: 10.1177/0148607195019004272. Available from: http://dx.doi.org/10.1177/0148607195019004272. [PubMed] [CrossRef] [Google Scholar]

23. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med. 1995;152(5 Pt 1):1545–1548. [PubMed] [Google Scholar]

24. Safe Practices for Parenteral Nutrition Formulations. National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition. JPEN J Parenter Enteral Nutr. 1998;22(2):49–66. doi: 10.1177/014860719802200249. Available from: http://dx.doi.org/10.1177/014860719802200249. [PubMed] [CrossRef] [Google Scholar]

25. Llop J, Sabin P, Garau M, Burgos R, Pérez M, Massó J, Cardona D, Sánchez Segura JM, Garriga R, Redondo S, Sagalés M, Ferrer D, Pons M, Vuelta M, Fàbregas X, Vitales M, Casasín T, Martínez J, Morató L, Soler M Hospital Pharmacy Artificial Nutrition Group of Catalonia. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr. 2003;22(6):577–583. doi: 10.1016/S0261-5614(03)00082-7. Available from: http://dx.doi.org/10.1016/S0261-5614(03)00082-7. [PubMed] [CrossRef] [Google Scholar]

26. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041–2047. doi: 10.1001/jama.290.15.2041. Available from: http://dx.doi.org/10.1001/jama.290.15.2041. [PubMed] [CrossRef] [Google Scholar]

27. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314(7093):1512–1515. [PMC free article] [PubMed] [Google Scholar]

28. Meier JJ, Deifuss S, Gallwitz B, Klamann A, Schmiegel W, Nauck MA. Einfluss einer eingeschränkten Glukosetoleranz auf das Langzeitüberleben nach akutem Myokardinfarkt The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA) [Influence of impaired glucose tolerance on long-term survival after acute myocardial infarction]. Dtsch Med Wochenschr. 2002;127(21):1123–1129. doi: 10.1055/s-2002-31529. (Ger). Available from: http://dx.doi.org/10.1055/s-2002-31529. [PubMed] [CrossRef] [Google Scholar]

29. Norhammar AM, Rydén L, Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999;22(11):1827–1831. doi: 10.2337/diacare.22.11.1827. Available from: http://dx.doi.org/10.2337/diacare.22.11.1827. [PubMed] [CrossRef] [Google Scholar]

30. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52(1):20–28. doi: 10.1002/ana.10241. Available from: http://dx.doi.org/10.1002/ana.10241. [PubMed] [CrossRef] [Google Scholar]

31. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–982. doi: 10.1210/jc.87.3.978. Available from: http://dx.doi.org/10.1210/jc.87.3.978. [PubMed] [CrossRef] [Google Scholar]

32. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–1367. doi: 10.1056/NEJMoa011300. Available from: http://dx.doi.org/10.1056/NEJMoa011300. [PubMed] [CrossRef] [Google Scholar]

33. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314(7090):1303–1306. [PMC free article] [PubMed] [Google Scholar]

34. Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care. 2001;24(9):1634–1639. doi: 10.2337/diacare.24.9.1634. Available from: http://dx.doi.org/10.2337/diacare.24.9.1634. [PubMed] [CrossRef] [Google Scholar]

35. Kim H, Son E, Kim J, Choi K, Kim C, Shin W, Suh O. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition. Am J Health Syst Pharm. 2003;60(17):1760–1766. [PubMed] [Google Scholar]

36. Angelico M, Della GP. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther. 2000;14(2 Suppl):54–57. doi: 10.1046/j.1365-2036.2000.014s2054.x. Available from: http://dx.doi.org/10.1046/j.1365-2036.2000.014s2054.x. [PubMed] [CrossRef] [Google Scholar]

37. Chung C, Buchman AL. Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction. Clin Liver Dis. 2002;6(4):1067–1084. doi: 10.1016/S1089-3261(02)00057-0. Available from: http://dx.doi.org/10.1016/S1089-3261(02)00057-0. [PubMed] [CrossRef] [Google Scholar]

38. Adamkin DH. Total parenteral nutrition-associated cholestasis: prematurity or amino acids? J Perinatol. 2003;23(6):437–438. doi: 10.1038/sj.jp.7210989. Available from: http://dx.doi.org/10.1038/sj.jp.7210989. [PubMed] [CrossRef] [Google Scholar]

39. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv Pediatr. 2003;50:245–267. [PubMed] [Google Scholar]

40. Sandhu IS, Jarvis C, Everson GT. Total parenteral nutrition and cholestasis. Clin Liver Dis. 1999;3(3):489–508, viii. doi: 10.1016/S1089-3261(05)70082-9. Available from: http://dx.doi.org/10.1016/S1089-3261(05)70082-9. [PubMed] [CrossRef] [Google Scholar]

41. Gleghorn EE, Merritt RJ, Subramanian N, Ramos A. Phenobarbital does not prevent total parenteral nutrition-associated cholestasis in noninfected neonates. JPEN J Parenter Enteral Nutr. 1986;10(3):282–283. doi: 10.1177/0148607186010003282. Available from: http://dx.doi.org/10.1177/0148607186010003282. [PubMed] [CrossRef] [Google Scholar]

42. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology. 1996;111(3):716–719. doi: 10.1053/gast.1996.v111.pm8780577. Available from: http://dx.doi.org/10.1053/gast.1996.v111.pm8780577. [PubMed] [CrossRef] [Google Scholar]

43. Spurr SG, Grylack LJ, Mehta NR. Hyperalimentation-associated neonatal cholestasis: effect of oral gentamicin. JPEN J Parenter Enteral Nutr. 1989;13(6):633–636. doi: 10.1177/0148607189013006633. Available from: http://dx.doi.org/10.1177/0148607189013006633. [PubMed] [CrossRef] [Google Scholar]

44. Buchman AL. Complications of long-term home total parenteral nutrition: their identification, prevention and treatment. Dig Dis Sci. 2001;46(1):1–18. doi: 10.1023/A:1005628121546. Available from: http://dx.doi.org/10.1023/A:1005628121546. [PubMed] [CrossRef] [Google Scholar]

45. Doty JE, Pitt HA, Porter-Fink V, Denbesten L. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease. Ann Surg. 1985;201(1):76–80. doi: 10.1097/00000658-198520110-00011. Available from: http://dx.doi.org/10.1097/00000658-198520110-00011. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

46. Kalfarentzos F, Vagenas C, Michail A, Vasilakos P, Markoy S, Kordossis T, Androulakis J. Gallbladder contraction after administration of intravenous amino acids and long-chain triacylglycerols in humans. Nutrition. 1991;7(5):347–349. [PubMed] [Google Scholar]

47. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet. 1990;170(1):25–31. [PubMed] [Google Scholar]

48. Cohen-Solal M, Baudoin C, Joly F, Vahedi K, D'Aoust L, De Vernejoul MC, Messing B. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res. 2003;18(11):1989–1994. doi: 10.1359/jbmr.2003.18.11.1989. Available from: http://dx.doi.org/10.1359/jbmr.2003.18.11.1989. [PubMed] [CrossRef] [Google Scholar]

49. Nishikawa RA. Intravenous pamidronate improves bone mineral density in home parenteral nutrition patients. Clin Nutr. 2003;22:88. doi: 10.1016/S0261-5614(03)80330-8. Available from: http://dx.doi.org/10.1016/S0261-5614(03)80330-8. [CrossRef] [Google Scholar]

50. Kaminski MV., Jr A review of hypersomolar hyperglycemic nonketotic dehydration (HHND): etiology, pathophysiology and prevention during intravenous hyperalimentation. JPEN J Parenter Enteral Nutr. 1978;2(5):690–698. doi: 10.1177/0148607178002005690. Available from: http://dx.doi.org/10.1177/0148607178002005690. [PubMed] [CrossRef] [Google Scholar]

51. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996;11(4):151–156. doi: 10.1177/0115426596011004151. Available from: http://dx.doi.org/10.1177/0115426596011004151. [PubMed] [CrossRef] [Google Scholar]

52. Owens JP, Geibig CB, Mirtallo JM. Concurrent quality assurance for a nutrition-support service. Am J Hosp Pharm. 1989;46(12):2469–2476. [PubMed] [Google Scholar]

53. Grünert A. Überwachung der Patienten mit Ernährungstherapie - Biophysikalische und biochemische Meßgrößen. [Monitoring patients on nutritional therapy--biophysical and biochemical measurement values]. Klin Anasthesiol Intensivther. 1990;40:193–195. (Ger). [PubMed] [Google Scholar]

54. Seidner DL. Parenteral nutrition-associated metabolic bone disease. JPEN J Parenter Enteral Nutr. 2002;26(5 Suppl):S37–S42. doi: 10.1177/014860710202600511. Available from: http://dx.doi.org/10.1177/014860710202600511. [PubMed] [CrossRef] [Google Scholar]

55. Kelly DG. Guidelines and available products for parenteral vitamins and trace elements. JPEN J Parenter Enteral Nutr. 2002;26(5 Suppl):S34–S36. doi: 10.1177/014860710202600510. Available from: http://dx.doi.org/10.1177/014860710202600510. [PubMed] [CrossRef] [Google Scholar]